Therapeutic Classification: none assigned
Pharmacologic Classification: antihistamines
Absorption: Some systemic absorption follows topical application.
Distribution: Widely distributed to tissues.
Metabolism/Excretion: Metabolized by the liver by the CYP2C19 and CYP2D6 isoenzymes; the CYP2C19 enzyme system exhibits genetic polymorphism; 1520% of Asian patients and 35% of White and Black patients may be poor metabolizers of CYP2C19 and may have significantly ↑ doxepin concentrations and an ↑ risk of adverse effects; the CYP2D6 enzyme system also exhibits genetic polymorphism; ∼7% of population may be poor metabolizers of CYP2D6 and may have significantly ↑ doxepin concentrations and an ↑ risk of adverse effects.Primarily excreted in the urine.
Half-Life: Desmethyldoxepin: 2852 hr.